Battle Over Part D Rebates Gets Tougher: AARP Endorses House Bill
Executive Summary
The pharmaceutical industry's campaign against legislation mandating drug rebates for low-income beneficiaries covered by Medicare Part D has gotten more challenging
You may also be interested in...
Chart: AARP Backing Away From Health Reform Activism
AARP Backing Away From Health Reform Activism
AARP's Lobbying For Drug Cost Controls Gets Spotlight At House Hearing
Subcommittee session serves as platform for advocacy group's pitch for closing the Medicare Part D coverage gap.
Merged House Bill Seeks More Part D Savings, Broader Medicaid Expansion
The health care reform bill unveiled by the House leadership Oct. 29 seeks increased drug savings for the Medicare Part D program through mandated rebates for products provided to low-income beneficiaries and by requiring HHS to negotiate drug pricing directly with manufacturers